T. Rowe Price Investment Management
ROIV icon

T. Rowe Price Investment Management’s Roivant Sciences ROIV Stock Holding History

T. Rowe Price Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,048
Closed -$45K – 881
2025
Q4 		$45K Sell
2,048
-581
-22% -$11.5K ﹤0.01% 669
2025
Q3 		$40K Buy
+2,629
New +$32.5K ﹤0.01% 665
2023
Q4 		– Sell
-10,649,397
Closed -$124M – 629
2023
Q3 		$124M Buy
+10,649,397
New +$120M 0.09% 236

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management's ROIV Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 2,048 shares — an estimated $45K sold.

T. Rowe Price Investment Management first reported a position in ROIV in Q3 2023 and held it in 3 quarters. The position peaked at $124M in Q3 2023. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • T. Rowe Price Investment Management reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 2,048 Roivant Sciences shares in Q1 2026, an estimated $45K.
  • T. Rowe Price Investment Management first reported a position in Roivant Sciences in Q3 2023 and held it in 3 quarters.
  • T. Rowe Price Investment Management's Roivant Sciences position peaked at $124M in Q3 2023.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.